HCN1 and neoplasm: Vaccinated mice were bled 6‐weeks post prime, 3‐weeks post tumor inoculation, and mice which received bolus CpG‐OVA‐HAC2 had lower anti‐OVA IgG1 antibody titers than mice which received CpG‐OVA‐HAC2 (Figure 6e).